Candriam SCA’s Auspex Pharmaceuticals ASPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-36,000
Closed -$3.61M – 693
2015
Q1
$3.61M Buy
+36,000
New +$2.4M 0.07% 306

Candriam SCA's ASPX Position: Q2 2015 in Review

Candriam SCA sold out of Auspex Pharmaceuticals (ASPX) in Q2 2015, closing a stake of 36,000 shares — an estimated $3.61M sold.

Candriam SCA first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $3.61M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Candriam SCA reported no remaining Auspex Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Candriam SCA sold 36,000 Auspex Pharmaceuticals shares in Q2 2015, an estimated $3.61M.
  • Candriam SCA first reported a position in Auspex Pharmaceuticals in Q1 2015 and held it in 1 quarter.
  • Candriam SCA's Auspex Pharmaceuticals position peaked at $3.61M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held Auspex Pharmaceuticals as of Q2 2015.

Based on Candriam SCA's 13F filing for Q2 2015, filed 29 Jul 2015.